Earnings Feed
Start Free
Home/Filings/4/0001883850-24-000050
4//SEC Filing

Fenimore Christopher R. 4

Accession 0001883850-24-000050

CIK 0000872589other
View on SEC.govCompany Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 4:03 PM ET

Size

11.4 KB

Accession

0001883850-24-000050

Insider Transaction Report

Form 4
Period: 2024-12-06
REGENERON PHARMACEUTICALS, INC.REGN
Fenimore Christopher R.
VP, Controller
Transactions
  • Tax Payment

    Common Stock

    2024-12-09$787.00/sh−1,140$897,180→ 16,756 total
  • Award

    Common Stock

    2024-12-06+2,591→ 17,896 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2024-12-06+9,979→ 9,979 total
    Exercise: $771.64Exp: 2034-12-06→ Common Stock (9,979 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    25

  • Common Stock

    (indirect: By Trust)
    25

  • Common Stock

    (indirect: By 401(k))
    1,515

  • Common Stock

    (indirect: By Trust)
    1,897
Footnotes (3)
  • [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
  • [F2]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
  • [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

→
Entity typeother

Related Parties

1
  • filerCIK 0001697422

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:03 PM ET
Size
11.4 KB
View on SEC.gov